Understanding the Banned Products

The essential aspect of this ban is that it targets both semi-synthetic and synthetic cannabinoid products. Semi-synthetic substances are chemically altered natural compounds, whereas synthetic products are completely manufactured.

The specific compounds that are now prohibited in France include H4-CBD and H2-CBD, as well as certain derivatives containing a chemical framework known as benzo[c]chromene, which is intricate and multifaceted.

In simplified terms, S-Aryl dibenzothiophenium salts can transform into 6H-benzo[c]chromenes through a specific chemical reaction initiated by light. This process activates a reaction that generates an aryl radical, which subsequently forms a new ring structure, ultimately producing the desired tricyclic systems through a series of stabilizing steps.

This light-activated reaction alters the original compounds' structure, potentially making them advantageous for medical purposes and enhancing the efficiency of creating new cannabis-based medications.

For those interested in the scientific intricacies, you can refer to the paper published by the American Chemical Society titled “Synthesis of 6H-Benzo[c]chromene Scaffolds from O-Benzylated Phenols through a C–H Sulfenylation/Radical Cyclization Sequence.”

According to the BMJ, pure cannabidiol (CBD) and cannabinol (CBN) remain authorized for use. The ANSM confirmed on June 4 that four specific products based on benzo[c]chromene are also still permitted.

Why the Ban?

The rationale behind banning these new cannabinoid derivatives lies in the associated risks. Let me briefly outline the reasons for this prohibition based on my research into these chemicals.

Cannabinoid derivatives have become popular due to their claimed health benefits, which range from alleviating pain to reducing anxiety. However, like any emerging substance, it is crucial to have a thorough understanding of their safety profile.

The ANSM's decision underscores the potential hazards of these newer derivatives. Reports of serious adverse effects and addiction risks have raised alarms, leading to this precautionary action by the regulatory body.

For context, synthetic and semi-synthetic cannabinoids can produce unpredictable effects on the human body. Unlike naturally occurring cannabinoids such as CBD and CBN, these modified compounds may interact with the body in ways that are not yet fully understood by scientists and healthcare professionals.

Years ago, I encountered young individuals who overdosed on synthetic marijuana, known as “spice” or “K2” in various regions. These synthetic cannabinoids can be significantly more potent than natural cannabis and can enter the bloodstream rapidly, resulting in severe and unpredictable reactions.

I have seen numerous young people, who obtained these substances illegally, suffer rapid overdoses. Tragically, some did not survive before help could arrive. I appreciate that in Australia, where I reside, there are strict controls over these substances, yet some individuals still find ways to purchase them illicitly.

According to the Penington Institute, “since 2001, Australia has recorded over 37,000 drug-induced fatalities, an alarming statistic that requires urgent attention from both governments and communities. In 2021, there were 2,231 drug-related deaths reported, with an astonishing 75% being unintentional.”

The National Institute on Drug Abuse (NIDA) indicates that these synthetic substances can lead to severe health complications, including rapid heart rate, nausea, aggressive behavior, suicidal thoughts, and even death as the brain struggles to process them safely.

> NIDA stated that “Research shows use of illicit synthetic cannabinoids is associated with severe health problems and can be **life-threatening.* Illicitly produced synthetic cannabinoids are typically added to liquid cartridges for vaping or mixed with dried, shredded plant material for smoking.”*

This unpredictability can result in serious health issues, which is why regulatory agencies like the ANSM in France are intervening to safeguard public health. I hope more governmental bodies follow suit due to these life-threatening risks.

> Earlier this year, the European Monitoring Center for Drug and Drug Addiction reported that “Health risks from HHC and other semi-synthetic cannabinoids remain poorly understood.”

What This Means for You

If you or someone in your circle utilizes cannabinoid products, it is crucial to remain informed about what you are consuming. Stick to products that have been thoroughly studied and endorsed by reputable health authorities. With guidance from qualified healthcare professionals, pure CBD and CBN have established safety profiles, making them safer alternatives compared to newer, less researched derivatives.

Moreover, this situation emphasizes the necessity of regulatory oversight in the rapidly evolving field of cannabinoid products.

In the absence of stringent regulations, consumers may be exposed to harmful substances masquerading as beneficial supplements. Substance abuse continues to be a global dilemma, worsening in certain regions while others manage to control it through robust legislation and regulatory enforcement.

Conclusion: Navigating a Changing Landscape

The realm of cannabinoid products is swiftly evolving, presenting both opportunities and risks that we must navigate prudently.

The ANSM's prohibition of specific cannabinoid derivatives serves as a reminder that not all cannabis-related products are created equal.

As we persist in exploring the potential advantages of cannabinoids, safety must be our priority, guided by scientific evidence in our choices.

The key takeaway is to stay informed, remain cautious, and always prioritize your health. By doing so, those interested in using these products for medical purposes can reap the benefits while minimizing risks, supported by qualified healthcare professionals.

As a long-time researcher, I encourage scientists, clinicians, and the public to advocate for thorough research and responsible regulation/enforcement to ensure the safe use of these intriguing substances, which I view as a double-edged sword.

Recently, I also explored the concerning rise of vaping and e-cigarettes, which has developed into a modern epidemic among youth, echoing the public health challenges of smoking from decades past.

Thank you for taking the time to read my insights. I wish you a healthy and fulfilling life.

Last year, I came across an insightful and eye-opening article regarding the ramifications of synthetic drugs by Dr. Yildiz. I highly recommend it, as it offers invaluable life lessons. Here’s a link for anyone interested to read it freely, as it is among my favorite pieces.

> If you write about health and science, I welcome you to join my publication. Here is the link to the initial submission guidelines. I also curate stories from the Health & Science publication on Medium.com. **Top 10 Stories Published on Health & Science Publication for Friends of Medium.**

Uplifting News About My New Publication

My new publication, Health and Science, has made a significant impact and is growing rapidly, similar to its predecessor, ILLUMINATION. I wrote my first newsletter yesterday, which garnered thousands of views in May 2024. You can read the details in my first newsletter titled Exciting Updates from the 1st Successful Month of Health and Science Pub on Medium.

Recently, I introduced three new writers to my Health and Science publication. More introductions will come soon. Meanwhile, let’s support Dr. ADAM TABRIZ, Naya Monroe, MA, LCDC-I, and Lawson Wallace.

> Meet Dr. Adam Tabriz, MD, on Health & Science Publication of ILLUMINATION.

> Meet Naya Monroe on My Health & Science Publication of ILLUMINATION on Medium.com.

> Meet Lawson Wallace on My Health and Science Publication on Medium.

I also curate narratives from ILLUMINATION publications. Here is a recent collection where you might discover stories on various topics.

Mike’s Favorite Stories on ILLUMINATION Publications — #150.

About Me

I am a retired scientist in my mid-70s with several grandchildren who motivate me to write on this platform. As a way to give back, I volunteer as an editor for ILLUMINATION publications, aiding numerous new writers. I welcome the opportunity to read, publish, and promote your stories. You can connect with me on LinkedIn, Twitter, and Quora, where I share stories I enjoy. Subscribe to my account to receive my posts directly in your inbox.